Treatments

2026: Is Your Practice Ready for In-Office Biologics? Operational Signs It’s Time to Expand

2026: Is Your Practice Ready for In-Office Biologics? Operational Signs It’s Time to Expand

Spring Allergies and Asthma: When Is It Time to Talk to Your Doctor About Biologic Therapy?

Key Considerations When Launching or Expanding an In-Office Infusion Program

IBS vs. IBD: What’s the Difference, and When Could Biologic Treatment Be Part of the Conversation?

What FDA’s New Biosimilar Development Push Could Mean for Infusion Practices in 2026

Changing Seasons, Changing Symptoms: Why Spring Can Affect Autoimmune Conditions

Improving Access to Biologics for Severe Asthma Management

Living With Rheumatoid Arthritis: Why Staying on Your Treatment Matters

Timing Matters: The Role of Biologic and Infusion Therapies in Slowing MS Progression